On Invalid Date, Cytek Biosciences (NASDAQ: CTKB) reported Q4 2023 earnings per share (EPS) of $0.04, up 33.33% year over year. Total Cytek Biosciences earnings for the quarter were $5.50 million. In the same quarter last year, Cytek Biosciences's earnings per share (EPS) was $0.03.
As of Q1 2024, Cytek Biosciences's earnings has grown year over year. Cytek Biosciences's earnings in the past year totalled -$12.15 million.
What is CTKB's earnings date?
Cytek Biosciences's earnings date is Invalid Date. Add CTKB to your watchlist to be reminded of CTKB's next earnings announcement.
What was CTKB's revenue last quarter?
On Invalid Date, Cytek Biosciences (NASDAQ: CTKB) reported Q4 2023 revenue of $58.23 million up 20.48% year over year. In the same quarter last year, Cytek Biosciences's revenue was $48.34 million.
What was CTKB's revenue growth in the past year?
As of Q1 2024, Cytek Biosciences's revenue has grown 17.67% year over year. This is 8.57 percentage points higher than the US Medical Devices industry revenue growth rate of 9.1%. Cytek Biosciences's revenue in the past year totalled $193.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.